Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-04

FDA Approved: BRIMONIDINE — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved Sandoz's original ANDA for brimonidine tartrate ophthalmic solution, establishing a generic version of this glaucoma medication to reduce intra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

ORIG AP for BRIMONIDINE (BRIMONIDINE TARTRATE)